Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2/PGE2 in experimental sialadenitis

[1]  Lingyun Sun,et al.  Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis , 2019, Theranostics.

[2]  N. Rouas-Freiss,et al.  Biological functions of mesenchymal stem cells and clinical implications , 2019, Cellular and Molecular Life Sciences.

[3]  W. Richter,et al.  Regulation of WNT5A and WNT11 during MSC in vitro chondrogenesis: WNT inhibition lowers BMP and hedgehog activity, and reduces hypertrophy , 2019, Cellular and Molecular Life Sciences.

[4]  Huaxi Xu,et al.  Increased GITRL Impairs the Function of Myeloid-Derived Suppressor Cells and Exacerbates Primary Sjögren Syndrome , 2019, The Journal of Immunology.

[5]  F. Figueroa,et al.  Umbilical Cord‐Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial , 2018, Stem cells translational medicine.

[6]  Lingyun Sun,et al.  Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells , 2018, Stem Cell Research & Therapy.

[7]  Yuni Fang,et al.  Bone marrow mesenchymal stem cells tune the differentiation of myeloid-derived suppressor cells in bleomycin-induced lung injury , 2018, Stem Cell Research & Therapy.

[8]  R. Jonsson,et al.  Current concepts on Sjögren's syndrome – classification criteria and biomarkers , 2018, European journal of oral sciences.

[9]  D. Edwards,et al.  TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy , 2018, Oncoimmunology.

[10]  Yayi Hou,et al.  Myeloid‐derived suppressor cells exacerbate Sjögren's syndrome by inhibiting Th2 immune responses , 2018, Molecular immunology.

[11]  Hongwei Chen,et al.  Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype. , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Jing Luo,et al.  Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren’s syndrome , 2018, Annals of the rheumatic diseases.

[13]  Xiaofang Wang,et al.  Salivary‐gland‐protective regulatory T‐cell dysfunction underlies female‐specific sialadenitis in the non‐obese diabetic mouse model of Sjögren syndrome , 2018, Immunology.

[14]  Yanyong Yang,et al.  Bibliometric analysis of global scientific activity on umbilical cord mesenchymal stem cells: a swiftly expanding and shifting focus , 2018, Stem Cell Research & Therapy.

[15]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.

[16]  O. Cinar,et al.  Umbilical cord mesenchymal stromal cell transplantations: A systemic analysis of clinical trials. , 2017, Cytotherapy.

[17]  Lingyun Sun,et al.  Serum IFN‐γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients , 2017, Stem cells translational medicine.

[18]  Xiang Gao,et al.  Human Umbilical Cord Mesenchymal Stem Cells Inhibit T Follicular Helper Cell Expansion through the Activation of iNOS in Lupus-Prone B6.MRL-Faslpr Mice , 2017, Cell transplantation.

[19]  J. Hua,et al.  Interactions between mesenchymal stem cells and the immune system , 2017, Cellular and Molecular Life Sciences.

[20]  C. Mavragani.  Mechanisms and New Strategies for Primary Sjögren's Syndrome. , 2017, Annual review of medicine.

[21]  D. Roy,et al.  Inactivated Mesenchymal Stem Cells Maintain Immunomodulatory Capacity. , 2016, Stem cells and development.

[22]  J. Xu,et al.  Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs. , 2016, Clinical science.

[23]  H. Hua,et al.  Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren’s Syndrome , 2016, Journal of dental research.

[24]  H. Tse,et al.  Mesenchymal stem cells and immunomodulation: current status and future prospects , 2016, Cell Death and Disease.

[25]  M. Glymenaki,et al.  Elimination of Granulocytic Myeloid‐Derived Suppressor Cells in Lupus‐Prone Mice Linked to Reactive Oxygen Species–Dependent Extracellular Trap Formation , 2015, Arthritis & rheumatology.

[26]  S. Cha,et al.  Mouse Models of Primary Sjogren's Syndrome. , 2015, Current pharmaceutical design.

[27]  H. Lee,et al.  Mesenchymal Stem/Stromal Cells Protect against Autoimmunity via CCL2-Dependent Recruitment of Myeloid-Derived Suppressor Cells , 2015, The Journal of Immunology.

[28]  T. Daemen,et al.  Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy , 2015, Oncoimmunology.

[29]  Juan Li,et al.  Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis , 2014, Annals of the rheumatic diseases.

[30]  Wei Cao,et al.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.

[31]  Xia Li,et al.  Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjögren's syndrome through the secretion of indoleamine 2,3-dioxygenase. , 2014, Rheumatology.

[32]  Xia Li,et al.  A CD8 T Cell/Indoleamine 2,3-Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.

[33]  J. Karp,et al.  Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.

[34]  J. Talmadge,et al.  History of myeloid-derived suppressor cells , 2013, Nature Reviews Cancer.

[35]  C. Riccardi,et al.  Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome. , 2013, Rheumatology.

[36]  M. Yen,et al.  Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-Derived Suppressor Cells via Hepatocyte Growth Factor/c-Met and STAT3 , 2013, Stem cell reports.

[37]  X. Mariette,et al.  Advances in understanding the pathogenesis of primary Sjögren's syndrome , 2013, Nature Reviews Rheumatology.

[38]  O. Lee,et al.  Mesenchymal Stem Cells Tune the Development of Monocyte-Derived Dendritic Cells Toward a Myeloid-Derived Suppressive Phenotype through Growth-Regulated Oncogene Chemokines , 2013, The Journal of Immunology.

[39]  Lingyun Sun,et al.  Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. , 2012, Blood.

[40]  M. Aller,et al.  Immunosuppressive properties of mesenchymal stem cells: advances and applications. , 2012, Current molecular medicine.

[41]  C. Jorgensen,et al.  Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology , 2011, Stem Cell Research & Therapy.

[42]  C. Divino,et al.  Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models , 2010, The Journal of Immunology.

[43]  S. Sandwick,et al.  Subsets, expansion and activation of myeloid-derived suppressor cells , 2010, Medical Microbiology and Immunology.

[44]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[45]  M. Weiss,et al.  Immune Properties of Human Umbilical Cord Wharton's Jelly‐Derived Cells , 2008, Stem cells.

[46]  P. Messina,et al.  Diagnostic evaluation of serial sections of labial salivary gland biopsies in Sjögren's syndrome. , 2007, Medicina oral, patologia oral y cirugia bucal.

[47]  V. Kuchroo,et al.  CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.

[48]  R. C. van der Veen,et al.  Mycobacteria‐induced Gr‐1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion , 2007, Journal of leukocyte biology.

[49]  S. Ostrand-Rosenberg,et al.  Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment. , 2015, Advances in cancer research.

[50]  F. Guan,et al.  Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. , 2011, Cellular immunology.

[51]  Krisztián Németh,et al.  Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.

[52]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..